← arxiv-scrape

arXiv Ideation — Test Run + Methodology

arxiv-scrape • 2026-07-13

Methodology

The goal: mine fresh arXiv preprints and surface ones that could seed a real project, game, or startup — with a red-team pass so we're not fooled by ideas that only sound good.

Pipeline

1. Fetch (fetch_papers.py) — pulls recent papers from the official arXiv API across 16 categories (CS, math, quant/econ, physics/bio), 5 each = 80 papers, sorted newest-first. Respects the API's >=3s rate limit. Writes papers.json (title, authors, summary, pdf, category).

2. Ideate — one Sonnet agent per 5-paper batch reads the abstracts and brainstorms 2-4 concrete ideas that apply the research to something the authors didn't intend. Grounded in what the paper actually enables, not "build an app with AI."

3. Score — every idea gets an independent Sonnet reviewer scoring it 0-10 on a rubric: is the research load-bearing or decorative? Is there a real user/market? Can a small team prototype it? Names the biggest risk and the strongest angle.

4. Rank + synthesize — ideas ranked by score; the top 6 go to a final Opus agent that writes the brief below with an opinionated "if I had to build one tonight" pick.

All the per-paper work runs in parallel (a workflow pipeline — ideas from one batch get scored while other batches are still ideating), so 80 papers finish in ~15 minutes.

What this test run was

A 2-batch slice (10 CS papers) to validate the pipeline before the full 80-paper run. It also caught two real bugs worth noting:

  • First attempt killed every idea. The red-team was prompted to be "ruthless" and default to rejecting — result: 70/70 ideas scored 7-9 on a kill scale and zero survived. A red-teamer that rejects 100% gives no signal. Fix: dropped the binary survive/die flag, switched to an honest 0-10 rubric, and always rank + take the top N so the brief can never come back empty.
  • The scoring now spreads (this run: 5-6 across the top 6). Nothing cracked 7/10 — but that's an honest read on 5 arbitrary CS papers, and the full 80-paper run should surface a stronger top end.
  • Cost

    This 10-paper test: 14 agents, ~218k tokens, 3.5 min. The full 80-paper run scales to roughly 1.5-1.8M tokens, ~15 min.


    Below is the actual brief this test produced — unedited.


    arXiv Ideation — Tonight's Best Bets

    Tonight's crop pulled six preprints from a single arXiv batch (2607.096xx), spanning multi-fidelity emulation, agentic HDL verification, medical XAI auditing, topological EEG, visual-document pretraining, and VLM spatial-dependence red-teaming. All six were pitched as products; my job below is to rank them on how much of the product is actually load-bearing on the research versus wishful bridging over a large engineering or market gap.

    Top Picks

    1. LLM-Powered HDL Fuzzer That Writes Its Own Testbenches — tool (2607.09616v1)

    Pitch: a CI plugin that reads a Verilog module's ports and comments, has an agentic LLM generate self-checking directed-random testbenches, and flags RTL bugs at PR time before the first sim run.

    Why now: agentic LLM coding loops are cheap and good enough that generating stimulus + assertions from a port signature is a genuine 2026-feasible workflow, not a 2023 fantasy. Why it's my top pick: the narrow wedge (smoke-test RTL, catch 60-70% of dumb corner-case bugs pre-sim) has a crisp before/after metric, needs no formal-tool integration for V1, and sells into a real, quantifiable pain (tapeout is expensive; verification engineers are scarce). It's a tool, not a moonshot startup — a small team can ship it.

    Biggest risk: the source is a 5-page position/survey paper with no working system, so the research provides permission, not proof. And the tempting V2 (formal coverage closure with SVA/PSL) is exactly where LLMs still hallucinate assumption-vs-assertion discipline — if the roadmap drifts there too early, latency and loop-count blow up CI viability.

    2. SocialLens: Spatial-Dependence Auditor for VLMs — tool (2607.09654v1)

    Pitch: a CI gate that occludes image regions and checks whether a VLM's correct answers actually come from the right pixels, catching spurious-correlation predictions that shatter under distribution shift.

    Why now: the CSB paper argues spatial dependence is the last systematic MLLM error category once detection/recognition/hallucination are largely solved — a clean "audit the one thing that's still broken" narrative for model-risk teams. Strongest angle: the masking method (occlude, score similarity degradation, rank human vs. model region importance) is reimplementable without the CSB dataset, so you can ship domain-agnostic "bring your own images + region annotations" tooling into an underserved gap — promotion gates check F1 today, almost never region attribution.

    Biggest risk: the paper is 100 social-interaction images with three coarse masks and a population-level correlation test — that is inspiration, not infrastructure. A real CI tool needs per-image pass/fail on specific model versions, plus domain-specific probes for medical/moderation. Most of the build is recreating research plumbing per customer, and the "last remaining error type" claim may not survive contact with other domains.

    3. XAI Trustmark: Certification for Medical AI Explanations — startup (2607.09649v1)

    Pitch: a third-party auditor that runs ConceptSMILE's perturbation pipeline against a medical-AI vendor's concept explanations and issues a scored trustworthiness report for FDA submissions and EU AI Act conformity.

    Why now: the EU AI Act is in force for Annex III medical devices, notified bodies must assess explainability, and no quantitative XAI audit standard exists yet — a real 12-18 month land-grab window before Big Four consultancies commoditize it. Strongest angle: regulatory timing plus a documented, replicable five-metric scorecard (R²=0.85 surrogate fidelity on retinal fundus) is a credible bid to become the de-facto technical standard, wedging in via ophthalmology and one notified-body partner.

    Biggest risk: single-domain validation. ConceptSMILE is demonstrated only on retinal fundus; extending the audit to CT/MRI or whole-slide pathology is unproven research, not engineering. If it doesn't generalize, clients two and three never close — and this needs a regulatory-affairs hire on day one, which most technical founders underweight.

    4. VisDoc: Visual-Document Pretraining Data Engine — startup (2607.09657v1)

    Pitch: sell the pipeline (not the weights) that renders a customer's proprietary document corpus as images and emits clean visual-pretraining batches, preserving layout knowledge OCR destroys.

    Why now: the paper's finding that visual pretraining beats text-only on the same corpora holds across multiple backbones — genuinely monetizable where layout is load-bearing (chemical diagrams, circuit schematics, FDA tables). Strongest angle: selling the data pipeline sidesteps competing with frontier labs on model quality and shortens the sales cycle versus licensing weights.

    Biggest risk: the moat is closing in real time. Frontier VLMs (Qwen2.5-VL, GPT-4o, Gemma 3, LLaMA 4) already early-fuse vision and text at pretraining, eroding the exact architectural gap the paper exploits, and incumbents (Mistral Forge, LandingAI DPT-2, the hyperscaler document services) already sell enterprise doc understanding with distribution and compute the paper's team can't match. Where OCR is already 98-99% (legal text), the entire premise evaporates.

    5. DreamBand: Sleep Wearable with Topological Dream Detection — startup (2607.09662v1)

    Pitch (better version): skip consumer hardware; sell PHINN-EEG's persistent-homology dream-state detection as a SaaS/API to sleep clinics and pharma CROs running REM-targeted drug trials on existing clinical EEG.

    Why now: Dynamic Betti Curves hit AUC 0.82-0.90 on the open DREAM database vs. a 0.70 PSD baseline — topology catching geometric EEG structure PSD misses, most valuable exactly where channel count isn't the bottleneck. Strongest angle: the B2B pivot avoids the hardware BOM, uses the validated 58-channel setups, and has a far shorter cycle than a Class II wearable.

    Biggest risk: the AUC numbers are the paper's own words "exploratory hypotheses pending empirical validation" — analytical projections, not experimental results. That's a credibility hole under any pitch. The consumer version is worse still: dry-electrode 4-8ch SNR collapse, real-time Vietoris-Rips on a BLE MCU is unsolved, and the lucid-dream market (~$127M, slow-growing, already contested by Muse S / Prophetic Halo) is small with brutal subscription churn.

    6. Multi-Fidelity Emulator Marketplace — startup (2607.09645v1)

    Pitch: a platform where researchers upload high- and low-fidelity simulators and Deep-GP-on-DAGs auto-builds a calibrated multi-fidelity emulator returning posteriors, not point estimates.

    Why now: the framework handles heterogeneously sampled intermediate observations and collider (explaining-away) nodes — the real structure of multi-fidelity scientific workflows — with a structured variational approximation that avoids per-task re-derivation.

    Strongest angle: forget the marketplace; go vertical SaaS in one domain (heavy-ion/plasma physics) with a domain-expert co-founder, where the DAG is well-defined, the sim stack is standardized (JETSCAPE/SMASH/UrQMD), and groups genuinely can't get enough ARCHER2 allocation.

    Biggest risk: the "upload your code" flow is a fantasy — researchers' simulators are undocumented Fortran/C++ messes, so onboarding collapses into bespoke integration per customer. And the DAG extension's marginal value over existing OSS (emukit, mogp_emulator, GPyTorch MFDGP handling the standard Kennedy-O'Hagan chain) only materializes for the sub-niche with genuine collider structure — a small slice of an already-tiny market. Lowest ranked because the gap between paper and product is almost entirely non-research.

    If I Had To Build One Tonight

    The HDL fuzzer (2607.09616v1). It's the only one where the product is a tool with a bounded scope, a self-evident buyer (fabless RTL teams staring down tapeout cost), and a metric that proves value on day one — bugs caught pre-sim versus post-sim — none of which depend on unvalidated preprint numbers or a multi-year enterprise sales cycle. The competitors on this list are all startups gated on either research generalization (Trustmark, DreamBand, Emulator) or a closing architectural window (VisDoc); this one just needs solid engineering on top of LLM capabilities that already exist. The one discipline required: refuse to chase formal-coverage closure in V1, because that's the hallucination-prone rabbit hole that would tank CI latency.

    Concrete first step: take three or four open-source Verilog modules from OpenTitan or a picoRV32-class core, hand-inject a handful of known corner-case bugs (off-by-one on a counter wrap, missing reset, FIFO full/empty edge), then prompt an agentic loop to generate self-checking directed-random testbenches from only the port list and comments. Run them under Verilator and measure the true hit rate on the injected bugs. If it catches 60%+ with zero human test-writing, you have your before/after demo and a fundable wedge; if it can't, you learned that cheaply tonight.